Breast cancer claims younger black female lives. If so, when should the screening begin?

Published Date: 26 Apr 2023

Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.

Read Full News

Latest News

Sep 18 2026 This Week in Cardiology

Another ESC recap, listener feedback on two trials, and a paper on GLP-1 effects on inflammation from the SELECT trial are the topics John Mandrola, MD, discusses in this week’s podcast.

Time to REACT Earlier: Is CVD Prevention Starting Too Late?

How reassuring is a low 10-year CV risk? REACT reveals how early silent atherosclerosis begins and asks whether CVD prevention should start sooner.

Never Too Late (or Too Early) for Lipid Lowering

ESC studies on statin use in patients over 70 years and identifying subclinical atherosclerosis via 3D ultrasonography of the carotid and femoral arteries and coronary CTA are discussed.

Narrative Videos to Improve Lung Cancer Screening Uptake

Short, veteran-led clips could stem fear, anxiety associated with screening

What the 2026 ESC Guidelines Mean for Primary Care

The guideline update is a revolution that will promote evidence-based, person-centered classification and management of heart failure.

Sep 11 2026 This Week in Cardiology

A second ESC recap plus two breaking stories on the failure of an investigational Lp(a) reducing drug and a new FDA approval of an AI-ECG app are covered by John Mandrola, MD

Todays Updates

Clinical Forum Weighs in: Biologic Selection in Asthma and COPD

Clinical Forum Weighs in: Biologic Selection in Asthma and COPD

Treatable Traits in Asthma and COPD: Clinical Forum Perspectives

Treatable Traits in Asthma and COPD: Clinical Forum Perspectives

Biologic Access in Asthma and COPD: Clinical Forum Perspectives

Biologic Access in Asthma and COPD: Clinical Forum Perspectives

FDA Grants Fast Track Status to EG-501 in Neuropsychiatric Lupus Marco Meglio

The designation follows phase 2 ClearMEMory data in which the oral NMDA receptor antagonist improved objective cognitive performance over placebo at 12 weeks.

MDS Congress 2026: Late-Breaking Data Snapshot Marco Meglio

A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.

New Phase 1 Study Tests Intrathecal Gene Therapy Agent INS1201 in Duchenne Muscular Dystrophy Marco Meglio

The phase 1 ASCEND trial is testing a single intrathecal dose of the investigational AAV9 gene therapy INS1201 in young boys with Duchenne muscular dystrophy.

Satralizumab Reduces MOGAD Relapse Risk in Phase 3 METEOROID Trial Louie Pasculli

Findings from the phase 3 METEOROID trial showed that satralizumab reduced the risk of relapse in patients with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.

Todays Updates

Clinical Forum Weighs in: Biologic Selection in Asthma and COPD

Clinical Forum Weighs in: Biologic Selection in Asthma and COPD

Treatable Traits in Asthma and COPD: Clinical Forum Perspectives

Treatable Traits in Asthma and COPD: Clinical Forum Perspectives

Biologic Access in Asthma and COPD: Clinical Forum Perspectives

Biologic Access in Asthma and COPD: Clinical Forum Perspectives

FDA Grants Fast Track Status to EG-501 in Neuropsychiatric Lupus Marco Meglio

The designation follows phase 2 ClearMEMory data in which the oral NMDA receptor antagonist improved objective cognitive performance over placebo at 12 weeks.

MDS Congress 2026: Late-Breaking Data Snapshot Marco Meglio

A quick-read roundup of 10 late-breaking abstracts from the 2026 MDS Congress, from phase 3 Parkinson disease readouts to long-term data in Huntington disease and Tourette syndrome, with the key results that matter for practice.

New Phase 1 Study Tests Intrathecal Gene Therapy Agent INS1201 in Duchenne Muscular Dystrophy Marco Meglio

The phase 1 ASCEND trial is testing a single intrathecal dose of the investigational AAV9 gene therapy INS1201 in young boys with Duchenne muscular dystrophy.

Satralizumab Reduces MOGAD Relapse Risk in Phase 3 METEOROID Trial Louie Pasculli

Findings from the phase 3 METEOROID trial showed that satralizumab reduced the risk of relapse in patients with relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.

Latest News

Another ESC recap, listener feedback on two trials, and a paper on GLP-1 effects on inflammation from the SELECT trial are the topics John Mandrola, MD, discusses in this week’s podcast.

How reassuring is a low 10-year CV risk? REACT reveals how early silent atherosclerosis begins and asks whether CVD prevention should start sooner.

ESC studies on statin use in patients over 70 years and identifying subclinical atherosclerosis via 3D ultrasonography of the carotid and femoral arteries and coronary CTA are discussed.

Short, veteran-led clips could stem fear, anxiety associated with screening

The guideline update is a revolution that will promote evidence-based, person-centered classification and management of heart failure.

A second ESC recap plus two breaking stories on the failure of an investigational Lp(a) reducing drug and a new FDA approval of an AI-ECG app are covered by John Mandrola, MD

News All Time

Ergonomics of Scoping: Staying Injury Free

Drs Benjamin Levy and Patrick Young discuss how gastroenterologists can protect themselves from repetitive-motion injuries in the endoscopy suite.

When Grief Was Called Hysteria

A young woman grieving a miscarriage was labeled "hysteria." Dr Loshi Rajen reflects on diagnostic bias, the enduring power of psychiatric labels, and the importance of recognizing normal grief.

The Heart of the Matter

How a cardiac procedure exposed the tension between a mother’s autonomy and her son’s medical expertise.

The Dose Is Too High: Rethinking TKI Dosing

Standard TKI doses are often too high for long-term care. Dr Mark Kris shares his strategy for smart dose reductions that protect patient outcomes.

Optimizing Therapy in Early Stage HER2+ Breast Cancer

Cure rates are climbing, and so is the complexity of getting there. Dr Yara Abdou takes a closer look at optimizing HER2+ early-stage breast cancer therapy.

The ‘Pack-Year’ Approach to Cardiac Risk Management

The Curbsiders share practical insights on navigating complex cardiac risk factors and optimizing cholesterol.

The Looming 100-Million Cancer Workforce Crisis

Global workforce inequities are widening the cancer survival gap. Prof David Kerr highlights the stark realities and calls for an improved training approach.

Are Smart Glasses the Future of Collaborative Surgery?

Orthopedic surgeon Amgad Nakhla is using smart glasses in theater to bring remote expertise into com-plex cases and support real-time decisions.

Thyroid: A Year in Review

Drs Kaniksha Desai and Anupam Kotwal discuss thyroid: a year in review.

Fast Five Quiz: PPF Management

What do you know about the management for progressive pulmonary fibrosis? Test your knowledge with this quick quiz.

CT Radiation Risk: Is it Time to Rethink Imaging?

Two high-impact studies link routine CT scans to significant lifetime cancer risks. Dr Maurie Markman discusses why we can no longer ignore the data.

Preview: New Thyroid Nodule Guidelines

Drs Kaniksha Desai and Victor Bernet discuss the new guidelines for thyroid nodules.

Migraine and Stroke: What's the Real Risk?

Neurologist Indu Subramanian and migraine expert Andrew Charles discuss the risk for stroke in patients with migraine.

De-Escalated Treatment for Early Breast Cancer Continues to Gain Momentum

More patients of all ages skip sentinel lymph node biopsy, get less aggressive RT or none at all

Pancreatic Cancer Risk Much Higher for Certain Group, Study Suggests

Long-term follow-up of low-risk pancreatic cystic lesions may be necessary

Creeping Gradients After TAVR Linked to Poor Longer-Term Outcomes

Registry tracked incidence, prognostic impact of early hemodynamic valve deterioration

Recommended News For You

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

Morning Immunotherapy Does Not Boost Lung Cancer Survival

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?

Revolutionary Cancer Tx Could Transform Autoimmune Disease

A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll

Recommended Articles For You

Community Survivorship Networks for Long-Term Cancer Wellness 

AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence 

How to Prevent Tumor Lysis Syndrome in Cancer Patients 

Clinical Pathways in Hematology in Clinical Decision-Making 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Effects of Recombinant Replacement Therapy Explained in Detailed Regarding Genetic Clotting Disorder.

2.

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

3.

Kate Middleton Announces Major Cancer Update

4.

New Nanoparticles Can Destroy Undruggable Cancer Proteins

5.

Future of Lab-Developed Tests Still Taking Shape

1.

How Cancer Cells Evade Immune Destruction and the Fight Back

2.

Menstrual Blood Changes in Iron-Deficiency States: Clinical Insights and Evidence-Based Management

3.

HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment

4.

The Future of Hematology: Innovations Every Doctor Should Know

5.

Reproductive Aging and Fertility Preservation Timing

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

How Nutrition Can Support Patients During Cancer Care

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

4.

Recognizing General Warning Signs of Cancer

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot